AptarGroup (AGT) Stock Price & Analysis
AGT Stock Chart & Stats
- Day’s Range
- EUR 113.10 - EUR 118.00
- 52-Week Range
- EUR 93.75 - EUR 123.90
- Previous Close
- EUR 112.80
- Volume
- 0
- Average Volume (3M)
- 31
- Market Cap
- EUR 7.81B
- Enterprise Value
- EUR 9.02B
- Total Cash (Recent Filing)
- EUR 212.30M
- Total Debt (Recent Filing)
- EUR 1.42B
- Price to Earnings (P/E)
- 33.0
- Beta
- 0.51
- Next Earnings
- Feb 18, 2027 (Est.)
- EPS Estimate
- 1.27
- Next Dividend Ex-Date
- N/A
- Dividend Yield
- 1.48%
Bulls Say, Bears Say
Bulls Say
Pharma Pipeline And Recurring Revenue
A broad development pipeline across multiple drug-delivery technologies supports future program wins and customer retention. The stated high proportion of repeat growing revenue adds durability, while exposure to biologics, GLP-1 medicines and other therapies can sustain demand beyond individual product cycles.
Broad-based Revenue Growth
Growth across dispensing, Pharma and material science solutions indicates that Aptar is not relying on a single end market for expansion. Broad segment participation can improve revenue resilience, support operating investment and reinforce the company’s position with brand and healthcare customers.
Balance Sheet And Cash Generation
Positive free cash flow, substantial liquidity and moderate leverage provide financial flexibility for capital investment, innovation and shareholder returns. This balance-sheet position can help Aptar continue funding growth initiatives while retaining capacity to manage operating volatility over the next several quarters.
Bears Say
Sustained Margin And Earnings Pressure
The decline in profitability shows that recent revenue growth is not fully translating into earnings expansion. Lower margins can constrain reinvestment and reduce operating leverage, particularly if unfavorable product mix, cost pressures or weaker segment execution persist through the coming quarters.
Beauty North American Execution Weakness
Beauty’s North American issues are broader than a temporary sales fluctuation because management identified lost share, subscale operations and multiple execution gaps. The required transformation is not expected to be quick or linear, creating a durable risk to margins, customer retention and segment recovery.
Lower Emergency Medicine Growth Baseline
The emergency medicine business faces a structural reset rather than merely a short-lived inventory correction. As destocking laps and naloxone growth normalizes at a lower rate, Aptar may lose a source of unusually strong expansion and continue facing mix and baseline uncertainty in Pharma.
AptarGroup News
AGT FAQ
What was AptarGroup’s price range in the past 12 months?
What is AptarGroup’s market cap?
When is AptarGroup’s upcoming earnings report date?
How were AptarGroup’s earnings last quarter?
Is AptarGroup overvalued?
Does AptarGroup pay dividends?
What is AptarGroup’s EPS estimate?
How many shares outstanding does AptarGroup have?
What happened to AptarGroup’s price movement after its last earnings report?
Which hedge fund is a major shareholder of AptarGroup?
What is the TipRanks Smart Score and how is it calculated?
AptarGroup Stock Smart Score
Company Description
AptarGroup
AptarGroup, Inc. specializes in developing and manufacturing solutions for dispensing, sealing, and advanced material science, catering to a broad spectrum of industries such as beauty, personal care, home care, and the pharmaceutical sector (including prescription drugs, consumer health care, and injectables), alongside the food and beverage markets. Its operations are structured into three key segments: Pharma, Beauty + Home, and Food + Beverage. The Pharma division offers critical components for the pharmaceutical industry, including pumps for nasal allergy remedies, metered dose inhaler valves vital for managing respiratory conditions like asthma and chronic obstructive pulmonary disease (COPD), elastomeric primary packaging for injectables, and sophisticated active material science innovations. The Beauty + Home segment primarily supplies the personal care and home care sectors with essential products such as pumps, various closures, aerosol valves, accompanying accessories, and sealing mechanisms. It also furnishes the beauty market with pumps and decorative elements. For the food and beverage industries, its Food + Beverage segment delivers a variety of dispensing and non-dispensing closures, specialized elastomeric flow control components, spray pumps, and aerosol valves. AptarGroup markets its offerings globally, utilizing its internal sales team, complemented by independent representatives and distributors across Asia, Europe, Latin America, and North America. The company is engaged in a strategic partnership with PureCycle Technologies LLC to pioneer the integration of ultra-pure recycled polypropylene into advanced dispensing applications. Additionally, it collaborates with Sonmol on the development of a digital platform providing therapies and services, with a particular focus on respiratory and other health conditions. Established in 1992, AptarGroup, Inc. maintains its corporate headquarters in Crystal Lake, Illinois.
- Sector
- Healthcare
- Industry
- Medical - Instruments & Supplies
- CEO
- Gael Touya
- Employees
- 14,000
- Website
- www.aptar.com
- Address
- 265 Exchange Drive, Crystal Lake, IL, 60014, US
AptarGroup (AGT) Earnings & Revenues
AGT Company Deck
AGT Earnings Call
Earnings Call SentimentPositive
The call was predominantly positive. Aptar reported 5% core sales growth across all three segments, strong underlying Pharma growth, robust pipeline activity, solid cash generation and a positive fourth-quarter outlook. However, profitability declined year-over-year, Beauty's North American operations remain a significant execution challenge, emergency medicine growth is expected to normalize at a lower rate, and the company recorded a substantial Russian subsidiary deconsolidation charge. Management expressed confidence in the portfolio and long-term opportunities while acknowledging that operational improvements, particularly in Beauty, will take time.
View all DE:AGT earnings summariesAGT Stock 12 Month Forecast
Average Price Target
Technical Analysis
Overall Consensus
| Indicator | Bullish | Neutral | Bearish |
|---|---|---|---|
| Overall Consensus | 15 | 3 | 4 |
| Technical Analysis | 3 | 3 | 4 |
| Moving Averages | 12 | 0 | 0 |
